Brief: Passage Bio Doses First Patient In Global Clinical Trial For Infantile Krabbe Disease, A Rare Fatal Pediatric Condition
10/03/2022 12:40
March 10 (Reuters) - Passage Bio Inc PASG.O :
* PASSAGE BIO DOSES FIRST PATIENT IN GLOBAL CLINICAL TRIAL
FOR
INFANTILE KRABBE DISEASE, A RARE FATAL PEDIATRIC CONDITION
Source text for Eikon: ID:nGNXHLDqw
Further company coverage: PASG.O